Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(JAGSNPHARM) Jagsonpal Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jagsonpal Pharmaceuticals | (JAGSNPHARM) share price targets

Complete technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM) by charts plus indicators, forecast predictions and share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Jagsonpal Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-02-25 View latest technical analysis

10 day averaged volume of Jagsonpal Pharmaceuticals is 367898

Date	Daily Closing Price	Open	High	Low	Volume
25 Tue Feb 2025	212.68	214.35	221.36	210.90	0.364 times
24 Mon Feb 2025	214.25	215.90	217.40	210.03	0.888 times
21 Fri Feb 2025	219.64	218.35	228.00	217.41	0.506 times
20 Thu Feb 2025	218.35	214.95	227.39	213.50	0.601 times
19 Wed Feb 2025	214.14	215.90	224.79	207.65	0.54 times
18 Tue Feb 2025	215.10	220.80	224.20	210.60	0.592 times
17 Mon Feb 2025	220.77	228.95	231.10	216.00	0.989 times
14 Fri Feb 2025	229.75	230.90	237.00	223.28	0.912 times
13 Thu Feb 2025	228.50	238.50	247.45	225.60	0.962 times
12 Wed Feb 2025	241.61	221.50	254.00	210.81	2.784 times

My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 217.4, but if it comes above 217.4, then a intra day buy could be more profitable.
If you take a sell trade below 217.4, then use 217.4 as stoploss and 194.8 as target. However if you take a buy trade in stock , then use 217.4 as stoploss and 236.27 as target.

Share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Target Type	Value
Downside Target	196.35
Downside Target	207.65
Upside Target	221.36
Upside Target	231.10
Upside Target	246.28
Upside Target	263.90
Upside Target	274.81
Upside Target	284.36
Upside Target	396.55
Upside Target	525.75
Upside Target	564.00
Upside Target	584.25
Upside Target	695.00
Upside Target	814.25
Upside Target	820.10

Intraday share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Target Type	Value
Downside Intraday Target	208.02
Downside Intraday Target	203.36
Upside Intraday Target	219.35
Upside Intraday Target	226.02
Upside Intraday Target	214.69

Weekly technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Date	Weekly Closing Price	Open	High	Low	Volume
25 Tue Feb 2025	212.68	215.90	221.36	210.03	0.388 times
21 Fri Feb 2025	219.64	228.95	231.10	207.65	0.448 times
14 Fri Feb 2025	229.75	270.00	274.81	210.81	1.183 times
07 Fri Feb 2025	266.65	250.88	284.36	246.28	0.849 times
31 Fri Jan 2025	249.60	245.05	263.90	199.50	0.477 times

Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Date	Monthly Closing Price	Open	High	Low	Volume
25 Tue Feb 2025	212.68	250.88	284.36	207.65	0.648 times
31 Fri Jan 2025	249.60	610.85	695.00	196.35	3.558 times
31 Tue Dec 2024	610.85	762.00	814.25	584.25	0.634 times
29 Fri Nov 2024	761.20	546.75	820.10	525.75	1.342 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Jagsonpal Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a BUY signal for Jagsonpal Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Jagsonpal Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a buy signal for Jagsonpal Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Jagsonpal Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 226.89 and Jagsonpal Pharmaceuticals (JAGSNPHARM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Jagsonpal Pharmaceuticals (JAGSNPHARM) stock. Volume based technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM) stock is negative.

Jagsonpal Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.